SCHEMBL4196685

SCHEMBL4196685

COC(=O)c1c(C)oc(C)c1S(=O)(=O)Nc1ccccc1CN[C@@H](C)CC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 1/20 0.44
GAA P10253 2/20 0.43
NPC1 O15118 1/20 0.43
KDM4E B2RXH2 3/20 0.39
PKM P14618 1/20 0.39
MAPT P10636 3/20 0.38
TP53 P04637 1/20 0.38
CNR1 P21554 1/20 0.38
POLB P06746 4/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 3/20 0.35
KIF11 P52732 1/20 0.34
CASP6 P55212 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
LMNA P02545 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197715 1.00 CCKBR (0.44) CCKBRGAANPC1KDM4EPKM
SCHEMBL4193122 0.94 PKM (0.43) CCKBRGAANPC1KDM4EPKM
SCHEMBL14343713 0.91 POLB (0.41) CCKBRKDM4EPKMMAPTPOLB
SCHEMBL4191171 0.84 CCKBR (0.45) CCKBRGAAKDM4EPKMPOLB
SCHEMBL4200028 0.83 CCKBR (0.44) CCKBRGAAKDM4EPKMPOLB
SCHEMBL14343960 0.82 KDM4E (0.41) KDM4EPKMMAPTPOLBMEN1
SCHEMBL14343947 0.81 KDM4E (0.39) KDM4EPKMMAPTPOLBMEN1
SCHEMBL4188478 0.80 NPSR1 (0.46) NPC1KDM4EPKMPOLBMEN1
SCHEMBL4198365 0.79 ALDH1A1 (0.48) KDM4EPKMMAPTPOLBMEN1
SCHEMBL4190033 0.79 ALDH1A1 (0.45) NPC1KDM4EPKMTP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 CCKBR 4629/4885GAA 175/4885NPC1 1859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.